http://rdf.ncbi.nlm.nih.gov/pubchem/patent/LT-IP600-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_38c981fa8340314d4a95cfa625cf4bf0 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J5-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J7-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-57 |
| filingDate | 1993-06-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7efca6cfad9ce116de1f61b8670d0783 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_07c665ce6927ae3d0f80cd5fc506ca06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_216d070094fade46b62aab2bcdf33e84 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8a7bc1aa8135e811826a7310d333b7d6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_df0895c473d26d59c6600557d07bce5e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_84877eb1d2ae6ee46e8dc5bdde2bb70c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6e6171ff630cc0f5e48f24640c80b394 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6eaff002df32a67891bb41be79cf0fff http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_421b032b20474df35f18450a3fd18536 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_63100d6614a8c3eb4bf4e4004f8fbdd5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4198045a4786aa8b7510f5036b60e714 |
| publicationDate | 1994-04-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | LT-IP600-A |
| titleOfInvention | NEW PREGNANT SCALE STEROIDS, PHARMACEUTICAL COMPOSITION AND METHOD OF ADMINISTRATION |
| abstract | The present invention relates to novel therapeutically active 21-aminosteroids having the formula @@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@ @@@ as a substitute, an amino group substituted with a branched C4-8 alkyl, alkenyl or alkynyl group, or a C4-10 cycloalkyl group containing 1-3 rings which may contain a C1-3 alkyl group (s); or @ R 1 and R 2 together form a spiro-heterocyclic secondary amino group having up to 10 carbon atoms and which may contain at least one oxygen atom as an additional heteroatom; or one of R 1 and R 2 is an unsubstituted heterocyclic secondary amino group having from 4 to 7 carbon atoms, and the other is the above-mentioned primary amino group, the above-mentioned spiroheterocyclic secondary amino group, or a heterocyclic secondary amino group having from 4 to 7 C atoms with Cl -4-alkyl (s) substituted; and n is 1 or 2, @ and their addition salts, and the pharmaceutical composition comprising these compounds. In addition, the invention is also contemplated for the preparation of the above compounds. Compounds of formula (I) are antioxidant, especially lipid. peroxidation inhibitory effect, and therefore may be useful in treating the pathological effects of lipid peroxidation in mammalian, including human, organisms. |
| priorityDate | 1992-06-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 31.